RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans

Angiogenic properties of the chemokine RANTES/CCL5

(2011) Nadine Suffee et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Acceleration of spinal fusion using COMP-angiopoietin 1 with allografting in a rat model

(2011) Byung-Hyun Park et al.   BONE

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression

(2010) Hanna Hlawaty et al.   BIOCHEMICAL PHARMACOLOGY

Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization

(2010) C. Cochain et al.   CARDIOVASCULAR RESEARCH

Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells

(2009) Faten Charni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice

(2009) Vincent Braunersreuther et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Role of the chemokines CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice

(2009) Lucíola S. Barcelos et al.   MICROVASCULAR RESEARCH

The basic residue cluster 55KKWVR59 in CCL5 is required for in vivo biologic function

(2009) Stephan Segerer et al.   MOLECULAR IMMUNOLOGY

Chemokines in Atherosclerosis

(2008) Alma Zernecke et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead

(2007) V. W.M. van Hinsbergh et al.   CARDIOVASCULAR RESEARCH